RxDoctor Payments Data

Ali Mahdavi, MD

Gynecologic Oncology · York, PANPI 1578628350

Payments from drug & device makers

What this record shows

This record is dominated by travel and lodging: $2,679 of the $4,448 with a category attached, or 60.2%. Medical Device Business Services, Inc. accounts for 63.4% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2022 at $1,539 and has fallen 74.2% since, to $397 in 2025.

$4,448in general payments, 2019–2025

Across 42 payments — averaging $105.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medical Device Business Services, Inc.$3K
  • Intuitive Surgical$714
  • GSK$342
  • Johnson & Johnson$195
  • AstraZeneca$125
  • Tesaro, Inc.$125
  • plus $127 from 4 others

What the payments were for

  • Travel & lodging$2,67960%
  • Food & beverage$1,72539%
  • Education$441%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,448 in reported general payments places this provider in the 75th percentile of 90 gynecologic oncology providers in Pennsylvania.

See all gynecologic oncology providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$48,853
Medicare patients
69
Services billed
169

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other gynecologic oncology in York

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →